Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px
Document › Details

Medigene AG. (10/28/15). "Press Release: Medigene to Participate in Three International Conferences". Martinsried.

Organisations Organisation Medigene AG (MDG1, Frankfurt, Prime Standard)
  Group Medigene (Group)
  Organisation 2 EBD Group GmbH (DE)
Products Product BIO-Europe 2015 München (Munich)
  Product 2 Jefferies 2015 London Healthcare Conference
Index terms Index term Medigene–Informa: partnering conference, 201511 supply service Medigene participates in BIO-Europe 2015 in Munich
  Index term 2 Medigene–Leucadia: investor conference, 201511 supply service Medigene presents at Jefferies Global Healthcare Conference London
Person Person Hofmann, Julia (Medigene 201604 PR/IR)
     


Medigene AG (MDG1, Frankfurt, Prime Standard) announces its participation in three upcoming conferences:


BIO-Europe 2015

Date: 2 - 4 November 2015
Location: Munich, Germany
Exhibitor: Booth 74
www.ebdgroup.com/bioeurope/


SITC 2015 Annual Meeting & Associated Programs

Date: 4 - 8 November 2015
Location: National Harbor, Maryland, USA
www.sitcancer.org/2015


Jefferies Global Healthcare Conference London

Date: 18 November 2015
Location: London, UK
www.jefferies.com/OurFirm/Conferences/325/248


Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies.

For more information, please visit www.medigene.com


This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.


Contact Medigene
Julia Hofmann, Anja Clausnitzer
Tel.: +49 - 89 - 20 00 33 - 33 01
Email: investor@medigene.com

   
Record changed: 2017-04-02

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px